C
Cocrystal Pharma, Inc. Common StockCOCP
Cocrystal Pharma Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2), and hepatitis C viruses. Cocrystal employs unique structure based technologies to create viable antiviral.
US StocksHealthcareSmall CapBiotechnologyIndustrials
COCP の価格トレンド
Cocrystal Pharma, Inc. Common Stock · TradingView フルチャート
NASDAQ:COCP